Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses
Research and development	$ 12,342	$ 5,141	$ 26,944	$ 10,457
General and administrative	10,889	3,169	19,361	6,023
Change in fair value of contingent consideration	1,637	313	2,038	612
Total operating expenses	24,868	8,623	48,343	17,092
Operating loss	(24,868)	(8,623)	(48,343)	(17,092)
Other income, net
Change in fair value of warrants liabilities	0	1	0	1
Interest income, net	3,014	147	5,091	260
Total other income, net	3,014	148	5,091	261
Net loss	(21,854)	(8,475)	(43,252)	(16,831)
Other comprehensive income (loss)
Net unrealized loss on marketable securities	(46)	0	(151)	0
Foreign currency translation adjustment	(1)	(16)	(2)	0
Total comprehensive loss	$ (21,901)	$ (8,491)	$ (43,405)	$ (16,831)
Net loss per common share basic	$ (0.57)	$ (0.81)	$ (1.16)	$ (1.69)
Net loss per common share diluted	$ (0.57)	$ (0.81)	$ (1.16)	$ (1.69)
Weighted-average common shares outstanding used to calculate basic net loss per common share	38,631,565	10,423,598	37,419,968	9,938,171
Weighted-average common shares outstanding used to calculate diluted net loss per common share	38,631,565	10,423,598	37,419,968	9,938,171